Peripheral and central kynurenine pathway abnormalities in major depression
Elisabeth R Paul1, Lilly Schwieler2, Sophie Erhardt2
1Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Center for Medical Imaging and Visualization, Linköping University, Linköping, Sweden.
Major depressive disorder (MDD) shows altered kynurenine pathway (KP) metabolites in both blood and cerebrospinal fluid. These KP changes correlate with body mass index (BMI), suggesting a link between metabolic disturbance and depression.
Area of Science:
- Neuroscience
- Immunology
- Metabolic Psychiatry
Background:
- Major depressive disorder (MDD) is linked to immune system dysfunction and altered tryptophan metabolism via the kynurenine pathway (KP).
- Pro-inflammatory cytokines may shift KP metabolism towards neurotoxic products, a hypothesis primarily tested peripherally.
- Previous research suggests MDD is associated with brain structure changes and metabolic disturbances like increased BMI.
Purpose of the Study:
- To investigate kynurenine pathway (KP) metabolite levels in both plasma and cerebrospinal fluid (CSF) of individuals with MDD.
- To examine the relationship between KP metabolite abnormalities, brain structure volumes (hippocampus, amygdala), and body mass index (BMI) in MDD.
Main Methods:
- Measured KP metabolite levels (picolinic acid (PIC), kynurenic acid (KYNA), quinolinic acid (QUIN)) in plasma and CSF of MDD patients and healthy controls.
- Assessed brain-structure volumes (hippocampal, amygdalar) using neuroimaging techniques.
- Correlated KP metabolite levels with brain volumes and body mass index (BMI) in the MDD group.
Main Results:
- MDD patients showed altered plasma KP metabolites: lower picolinic acid (PIC), lower kynurenic/quinolinic acid (KYNA/QUIN) ratio, and lower PIC/QUIN ratio, but increased QUIN levels.
- Cerebrospinal fluid (CSF) analysis revealed lower PIC levels in MDD patients.
- Confirmed reduced hippocampal and amygdalar volumes in MDD, positively correlated with plasma KYNA/QUIN ratio. Increased BMI in MDD correlated inversely with plasma/CSF PIC and PIC/QUIN, and positively with plasma QUIN.
Conclusions:
- Findings partially support previous peripheral KP alterations in MDD and extend them to the CSF.
- Novelly demonstrates that kynurenine pathway (KP) metabolite abnormalities are associated with metabolic disturbances (BMI) in depression.
- The direct relationship between KP metabolites and depression-associated brain atrophy may be less pronounced than previously hypothesized.
More Related Videos
10:38Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
Published on: May 9, 2020
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents
Depressive Disorders: MDD and Dysthymia
Drugs Affecting Neurotransmitter Synthesis
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
